Results 161 to 170 of about 8,157,530 (188)
Some of the next articles are maybe not open access.

Thyroid-Associated Ophthalmopathy

2011
Eye symptoms are a common feature of Graves’ disease, where the symptoms have an underlying immunological cause. Several designations have been used: endocrine ophthalmopathy, dysthyroid orbitopathy, dysthyroid ophthalmopathy, orbitopathy, infiltrative ophthalmopathy and thyroid-associated ophthalmopathy (TAO).
Ernst Nyström   +4 more
openaire   +1 more source

Azathioprine in the treatment of thyroid-associated ophthalmopathy

Acta Endocrinologica, 1990
Abstract Azathioprine is used in the treatment of thyroid-associated ophthalmopathy, but its effectiveness has not been evaluated. In the present study 20 patients with moderately severe ophthalmopathy were recruited; 10 patients received azathioprine and the other 10 matched patients served as controls. During the treatment period (lasting 1 year) and
P, Perros   +3 more
openaire   +2 more sources

The Diagnosis and Treatment of Thyroid-Associated Ophthalmopathy

Aesthetic Plastic Surgery, 2011
Little is written in the plastic surgery literature about thyroid-associated ophthalmopathy (TAO), a condition that is separate from Graves-Basedow disease and may not be accompanied by hyperthyroidism. Many patients with this disease frequently seek periocular aesthetic reconstruction prior to medical workup.This study presents a comprehensive review ...
Daniel J, Gould   +2 more
openaire   +2 more sources

Medical Treatment for Thyroid-Associated Ophthalmopathy

Thyroid, 2002
The medical management of thyroid-associated ophthalmopathy has been, and remains a clinical challenge. Several drugs have been used. Systemic steroids seem to be beneficial in patients with active disease. The evidence for the remaining drugs reported to be potentially useful, is unconvincing.
Petros, Perros, Pat, Kendall-Taylor
openaire   +3 more sources

Sinusitis in Thyroid Associated Ophthalmopathy

American Journal of Rhinology, 1993
In 19 patients with thyroid associated ophthalmopathy undergoing orbital decompression, histologic examination of paranasal sinus mucosa revealed moderate to severe inflammatory alterations in all patients. Only 2/19 patients had a history of chronic sinusitis.
S. Davris   +3 more
openaire   +1 more source

Animal Models of Thyroid-Associated Ophthalmopathy

Thyroid, 2002
Thyroid-associated ophthalmopathy (TAO) is an autoimmune condition most frequently associated with Graves' disease (GD). The thyrotropin receptor (TSHR) is an important target of the autoimmune response in both disorders. The last 5 years have seen some progress in the development of animal models, induced with TSHR preparations and reproducing some or
openaire   +2 more sources

Progress in Thyroid-Associated Ophthalmopathy

Thyroid, 2002
185 AN INTERNATIONAL SYMPOSIUM on progress in thyroid-associated ophthalmopathy (TAO) was held as a satellite to the 12th International Thyroid Congress, in Kyoto. The program addressed basic research and clinical management aspects of TAO. The symposium comprised 19 invited lectures and a poster session.
Yuji Hiromatsu, Jack R. Wall
openaire   +1 more source

Thyroid-Associated Ophthalmopathy and Dermopathy

2007
Graves’ ophthalmopathy [thyroid-associated ophthalmopathy (TAO)] and dermopathy [thyroid-associated dermopathy (TAD)] are extrathyroidal manifestations of Graves’ disease, which should be viewed as a multisystem autoimmune disease involving thyrocytes but also orbital and pretibial fibroblasts. Smoking is a risk factor for TAO, and cessation of smoking
openaire   +2 more sources

Thyroid-Associated Ophthalmopathy and Dermopathy

1999
Various names have been given to the eye signs associated with autoimmune thyroid disease—Graves’ ophthalmopathy, endocrine exophthalmos, ophthalmic Graves’ disease, and so on—but the term thyroid-associated ophthalmopathy (TAO) is now generally accepted as the best, providing recognition that the condition is not always associated with Graves’ disease.
openaire   +1 more source

Home - About - Disclaimer - Privacy